The new study that will further fuel the controversy over pharma IP rights: https://t.co/7XzwfdGBX1
Chinese battery maker buys 100+ Google patents after being hit with US lawsuit https://t.co/PgmySL8cCu
USPTO Director Iancu, who has spoken of a "perception problem" at the PTAB, will soon have the opportunity to appoi… https://t.co/ogONUYQfv9
A recent report sheds new light on the patent estates protecting the US’s best-selling drugs. Revealing that over 100 applications are made on average for patents relating to blockbuster drugs, with dozens of assets being granted, the study makes plain the scale of the legal challenge facing many biosimilar producers seeking to launch their products. Released at a time of intense...
Recent USPTO assignments data shows the first known third-party IP acquisition by Amperex Technology Limited (ATL), a Hong Kong-based maker of lithium-ion batteries. According to the filing, Alphabet unit Google dealt 139 former Motorola assets to the company after first advertising them for sale back in 2015. IAM readers may remember ATL from a story we published last year on the...
Exit of PTAB chief judge gives Iancu further opportunity to put his own imprint on agency leadership
The news that David Ruschke, chief judge of the Patent Trial and Appeal Board (PTAB), is leaving his role to take up a new position at the USPTO took much of the DC patent community by surprise. After the move was disclosed in a town hall meeting on Tuesday and a memo from Director Iancu was circulated internally, PTAB practitioners started to pick up on events and by that evening it had hit...
Ericsson has a world-class portfolio of cellular SEPs which it is keen to license on FRAND terms, but the long-awaited decision of a California court in a case involving the Swedish company and TCL may not have correctly valued the portfolio